ESCRS - Blended Vision with Enhanced Monofocal IOL
IOL

Blended Vision with Enhanced Monofocal IOL

Study results show greater patient satisfaction with this targeted approach.

Blended Vision with Enhanced Monofocal IOL
Dermot McGrath
Dermot McGrath
Published: Monday, July 3, 2023

Implanting an enhanced monofocal IOL using a blended vision approach provided good levels of spectacle independence for intermediate and near distances and improved functional performance in daily life, according to a recent study.

“Our study showed patients implanted with the Tecnis Eyhance lens (Johnson & Johnson Vision) experienced improved spectacle independence for intermediate and near vision when comparing patients targeted for blended vision using a mini-monovision to control patients targeted for emmetropia,” Dr Reem Aziz said.

Explaining the rationale for the study, Dr Aziz noted prediction errors could make monovision targets difficult to achieve. And even when outcomes do match refractive targets, adaptation to binocular visual function is not always easy for patients using standard monofocal lens technology.

“The problem is more than 25% of all cataract patients are affected by a prediction error of more than 0.5 D, and more than 7% by a prediction error of more than 1.0 D,” she said.

“With this in mind, we wanted to look at the possibility of using an IOL that would achieve a broader landing zone on the defocus curve and give some leeway in the prediction error.”

The Tecnis Eyhance is a non-diffractive monofocal IOL with a modified anterior surface and continuous power profile from the periphery to the centre of the lens, allowing for a wider range of vision without an increase in photic phenomena or a decrease in contrast sensitivity, Dr Aziz explained.

The retrospective multicentre study included 88 eyes of 44 patients who underwent cataract surgery or refractive lens exchange with implantation of the Tecnis Eyhance IOL between August 2020 and December 2022. The procedure aimed for blended vision in 29 patients with a target of emmetropia in the dominant eye and a target of myopia ranging from -0.5 D to -1.5 D in the non-dominant eye. Key outcomes assessed included three-month postoperative uncorrected visual acuities at distance, intermediate, and near, defocus curves, spectacle independence, and visual function as evaluated by the NEIVFQ questionnaire.

Based on the spectacle independence questionnaire, the frequency of all study participants who were spectacle-free for distance, intermediate, and near activities was 80%, 64%, and 34%, respectively.

“What was interesting was spectacle independence was achieved in 72% for intermediate vision and 38% for near vision in blended vision patients, compared to 47% and 27% for controls, respectively,” Dr Aziz noted. Moreover, the average subjective visual function score for those who completed the NEI-VFQ questionnaire was 74.6% preoperatively and 91.3% three months postoperatively.

“This reflected the fact that patients were very happy overall with the performance of the lens,” she concluded. “Spectacle independence is very important to patients, and those targeted for blended vision did better at intermediate and near distances.”

Dr Aziz gave this presentation at the 2023 ESCRS Winter Meeting in Vilamoura, Portugal.

Reem Aziz MD is a post-graduate research fellow at Precision Cornea Centre and an incoming ophthalmology resident at the University of Ottawa, Canada.

reem@precisioncornea.com

Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...